Baseline total metabolic volume (TMTV) to predict the outcome of patients with advanced Hodgkin lymphoma (HL) enrolled in the AHL2011 LYSA trial.

Rene-Olivier, Casasnovas; Salim, Kanoun; Ilan, Tal; Anne-Segolene, Cottereau; Veronique, Edeline; Pauline, Brice; Reda, Bouabdallah; Gilles A., Salles; Aspasia, Stamatoullas; Jehan, Dupuis; Oumedaly, Reman; Thomas, Gastinne; Bertrand, Joly; Kamal, Bouabdallah; Emmanuelle, Nicolas-Virelizier; Marc, Andre; Nicolas, Mounier; Christophe, Ferme; Michel, Meignan; Alina, Berriolo-Riedinger

doi:10.1200/jco.2016.34.15_suppl.7509

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

Baseline total metabolic volume (TMTV) to predict the outcome of patients with advanced Hodgkin lymphoma (HL) enrolled in the AHL2011 LYSA trial.

作者：Rene-Olivier, Casasnovas; Salim, Kanoun; Ilan, Tal; Anne-Segolene, Cottereau; Veronique, Edeline; Pauline, Brice; Reda, Bouabdallah; Gilles A., Salles; Aspasia, Stamatoullas; Jehan, Dupuis; Oumedaly, Reman; Thomas, Gastinne; Bertrand, Joly; Kamal, Bouabdallah; Emmanuelle, Nicolas-Virelizier; Marc, Andre; Nicolas, Mounier; Christophe, Ferme; Michel, Meignan; Alina, Berriolo-Riedinger

来源：Journal of Clinical Oncology, 2016, 34(15_suppl): 7509-7509.

DOI：10.1200/jco.2016.34.15_suppl.7509